Fluarix GlaxoSmithKline - Treatment for Influenza Vaccination
Fluarix is indicated for adults 18 and older against influenza disease. This approval will help toward increasing flu vaccine supply in the United States for the 2005/2006 Flu Season.Related Articles:
FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use - October 19, 2009
GlaxoSmithKline Submits Biologics License Application for FDA Approval of Fluarix - May 25, 2005
FDA Drug Approvals Archive
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Aug | Oct | Dec
